Synthesis, spectroscopic characterization and anticancer potential studies of organoruthenium(II) arene dithiocarbamate complexes

References

• Gasser G, Ott I, Metzler-Nolte N. Organometallic anticancer compounds. J Med Chem. 2011;54:3–25. doi:10.1021/jm100020w
   PubMed Web of Science ®Google Scholar
• WoŸniak K, Błasiak J. Recognition and repair of DNA-cisplatin adducts. Acta Biochim Pol. 2002;49:583–596. doi:10.18388/abp.2002_3768
   PubMed Web of Science ®Google Scholar
• Rosenberg B, Van Camp L, Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature. 1965;205:698–699. doi:10.1038/205698a0
   PubMed Web of Science ®Google Scholar
• Amir MK, Khan SZ, Hayat F, et al. Anticancer activity, DNA-binding and DNA-denaturing aptitude of palladium(II) dithiocarbamates. Inorg Chim Acta. 2016;451:31–40. doi:10.1016/j.ica.2016.06.036
   Web of Science ®Google Scholar
• Johnson NP, Butour J-L, Villani G, et al. Metal antitumor compounds: the mechanism of action of platinum complexes. In: Ruthenium other non-platinum metal complexes in cancer chemotherapy. Springer; 1989. p. 1–24. doi:10.1007/978-3-642-74760-1_1
   Google Scholar
• Fregona D, Giovagnini L, Ronconi L, et al. Pt(II) and Pd(II) derivatives of ter-butylsarcosinedithiocarbamate: synthesis, chemical and biological characterization and in vitro nephrotoxicity. J Inorg Biochem. 2003;93:181–189. doi:10.1016/S0162-0134(02)00571-8
   PubMed Web of Science ®Google Scholar
• Sava G, Zorzet S, Giraldi T, et al. Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms. Euro J Cancer Clin Oncol. 1984;20:841–847. doi:10.1016/0277-5379(84)90223-2
   PubMedGoogle Scholar
• Banerjee S, Banerjee S. Metal-based complexes as potential anti-cancer agents. Anticancer Agents Med. Chem. 2022;22:2684–2707. doi:10.2174/1871520622666220331085144
   PubMed Web of Science ®Google Scholar
• Clarke MJ. Ruthenium metallopharmaceuticals. Coord Chem Rev. 2003;236:209–233.
   Web of Science ®Google Scholar
• Brabec V, Novakova O. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Drug Resist Updat. 2006;9:111–122. doi:10.1016/j.drup.2006.05.002
   PubMed Web of Science ®Google Scholar
• Rademaker-Lakhai JM, Van Den Bongard D, Pluim D, et al. A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent. Clin Cancer Res. 2004;10:3717–3727. doi:10.1158/1078-0432.CCR-03-0746
   PubMed Web of Science ®Google Scholar
• Groessl M, Reisner E, Hartinger CG, et al. Structure−activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L=imidazole, indazole, 1, 2, 4-triazole, 4-amino-1, 2, 4-triazole, and 1-methyl-1, 2, 4-triazole): Aquation, redox properties, protein binding, and antiproliferative activity. J Med Chem. 2007;50:2185–2193. doi:10.1021/jm061081y
   PubMed Web of Science ®Google Scholar
• Alessio E. Thirty years of the drug candidate NAMI-A and the myths in the field of ruthenium anticancer compounds: a personal perspective. Eur J Inorg Chem. 2017;2017:1549–1560. doi:10.1002/ejic.201600986
   Google Scholar
• Hartinger CG, Jakupec MA, Zorbas-Seifried S, et al. Kp1019, A new redox-active anticancer agent – preclinical development and results of a clinical phase I study in tumor patients. Chem Biodivers. 2008;5:2140–2155. doi:10.1002/cbdv.200890195
   PubMed Web of Science ®Google Scholar
• Scintilla S, Brustolin L, Gambalunga A, et al. Ru(III) anticancer agents with aromatic and non-aromatic dithiocarbamates as ligands: loading into nanocarriers and preliminary biological studies. J Inorg Biochem. 2016;165:159–169. doi:10.1016/j.jinorgbio.2016.11.018
   PubMed Web of Science ®Google Scholar
• Matveevskaya VV, Pavlov DI, Sukhikh TS, et al. Arene–Ruthenium(II) complexes containing 11H-Indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime: synthesis, characterization, cytotoxicity, and catalytic transfer hydrogenation of aryl ketones. ACS Omega. 2020;5(19):11167–11179. doi:10.1021/acsomega.0c01204
   PubMed Web of Science ®Google Scholar
• Ganeshpandian M, Loganathan R, Suresh E, et al. New ruthenium(II) arene complexes of anthracenylappended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity. Dalton Trans. 2014;43:1203–1219. doi:10.1039/C3DT51641E
   PubMed Web of Science ®Google Scholar
• Iida J, Bell-Loncella ET, Purazo ML, et al. Inhibition of cancer cell growth by ruthenium complexes. J Transl Med. 2016;14:48. doi:10.1186/s12967-016-0797-9
   PubMed Web of Science ®Google Scholar
• Hikisz P, Namiecińska E, Paneth P, et al. Mechanistic studies of arene–ruthenium(II) complexes with carbothioamidopyrazoles as alternative cancer drugs. Molecules. 2023;28:3969. doi:10.3390/molecules28093969
   PubMed Web of Science ®Google Scholar
• Guler S, Kayali HA, Sadan EO, et al. Half-sandwich arene ruthenium(II) thiosemicarbazone complexes: evaluation of anticancer effect on primary and metastatic ovarian cancer cell lines. Front Pharmacol. 2022;13:882756. doi:10.3389/fphar.2022.882756
   PubMed Web of Science ®Google Scholar
• Furrer J, Süss-Fink G. Thiolato-bridged dinuclear arene ruthenium complexes and their potential as anticancer drugs. Coord Chem Rev. 2016;309:36–50. doi:10.1016/j.ccr.2015.10.007
   Web of Science ®Google Scholar
• Namiecinska E, Grazul M, Sadowska B, et al. Arene-Ruthenium(II) complexes with carbothiamidopyrazoles as a potential alternative for antibiotic resistance in human. Molecules. 2022;27:468. doi:10.3390/molecules27020468
   PubMed Web of Science ®Google Scholar
• Ajibade PA, Andrew FP. Synthesis, characterization, and in vitro anticancer studies of chlorido(triphenylphosphine) ruthenium(II) dithiocarbamate complexes. Phosphorus Sulfur Silicon Relat Elem. 2021: 1–7. doi:10.1080/10426507.2021.1925671
   Web of Science ®Google Scholar
• Paca AM, Ajibade PA, Andrew FP, et al. Synthesis, X-ray crystal structures and anticancer studies of four Pd(II) dithiocarbamate complexes. Arabian J Chem. 2021;14:1–12. doi:10.1016/j.arabjc.2021.103326
   Web of Science ®Google Scholar
• McCubbin QJ, Stoddart FJ, Welton T, et al. Dithiocarbamate-functionalized dendrimers as ligands for metal complexes. Inorg Chem. 1998;37:3753–3758. doi:10.1021/ic980067b
   PubMed Web of Science ®Google Scholar
• Yao W-R, Liu Z-H, Zhang Q-F. Chloro(η6-p-cymene)(diethyldithiocarbamato-κ2S, S)ruthenium(II). Acta Crystallogr Sect E Struct Rep Online. 2003;59:m303–m305. doi:10.1107/S1600536803008079
   Google Scholar
• Ajibade PA, Fatokun AA, Paca AM. Synthesis, crystal structure, and anticancer studies of organoruthenium(II) p-cymene N-phenyldithiocarbamate complex. J Mol Struct. 2023;1292:136102. doi:10.1016/j.molstruc.2023.136102
   Web of Science ®Google Scholar
• Ajibade PA, Fatokun AA, Andrew FP. Synthesis, characterization and anticancer studies of Mn(II), Cu(II), Zn(II) and Pt(II) dithiocarbamate complexes-crystal structures of the Cu(II) and Pt(II) complexes. Inorg Chim Acta. 2020;504:119431. doi:10.1016/j.ica.2020.119431
   Web of Science ®Google Scholar
• Hogarth G. Metal-dithiocarbamate complexes: chemistry and biological activity. Mini Rev Med Chem. 2012;12:1202–1215. doi:10.2174/138955712802762095
   PubMed Web of Science ®Google Scholar
• Oluwalana AE, Ajibade PA. Synthesis and crystal structures of Pb(II) dithiocarbamates complexes: precursors for PbS nanophotocatalyst. Sulfur Chem. 2020;41(2):182–199. doi:10.1080/17415993.2019.1703986
   Web of Science ®Google Scholar
• Ajibade PA, Botha NL. Structural and optical studies of silver sulfide nanoparticles from silver(I) dithiocarbamate complex: molecular structure of ethylphenyl dithiocarbamato silver(I). J Sulfur Chem 2020;41(6):657–671. doi:10.1080/17415993.2020.1784895
   Web of Science ®Google Scholar
• Solomane N, Ajibade PA. Synthesis and crystal structure of bis(thiomorpholinyldithiocarbamato)Cu(II) complex and its use as precursor for CuS nanoparticles photocatalyst for the degradation of organic dyes. J Sulfur Chem 2021;42:167–179. doi:10.1080/17415993.2020.1822838
   Web of Science ®Google Scholar
• Gilewska A, Barszcz B, Masternak J, et al. Similarities and differences in d6 low-spin ruthenium, rhodium and iridium half-sandwich complexes: synthesis, structure, cytotoxicity and interaction with biological targets. J Bio Inorg Chem. 2019;24:591–606. doi:10.1007/s00775-019-01665-2
   PubMed Web of Science ®Google Scholar
• Uivarosi V, Badea M, Aldea V, et al. Thermal and spectral studies of palladium(II) and platinum(IV) complexes with dithiocarbamate derivatives. J Therm Anal Calorim. 2013;111:1177–1182. doi:10.1007/s10973-012-2315-5
   Web of Science ®Google Scholar
• Dou Y-H, Xu S-D, Chen Y, et al. Synthesis, characterization, and anticancer activity of dithiocarbamate ruthenium(II) complexes. Phosphorus Sulfur Silicon Relat Elem. 2017;192:1219–1223. doi:10.1080/10426507.2017.1359594
   Web of Science ®Google Scholar